Submitted by Anonymous (not verified) on 25 August 2023 - 14:54
Human medicines European public assessment report (EPAR): Kanuma, sebelipase alfa, Lipid Metabolism, Inborn Errors, Date of authorisation: 28/08/2015, Revision: 10, Status: Authorised
Source: